Meiji Seika Pharma to Buy 7.9% Stake in Arcturus Therapeutics for $50 Million
The proposed $50 million stake purchase is a disclosed corporate transaction involving Arcturus Therapeutics.
The proposed $50 million stake purchase is a disclosed corporate transaction involving Arcturus Therapeutics.